Effect of Dapagliflozin on Nighttime Blood Pressure in Type 2 Diabetes
Clinical trial NCT03887416 · UNKNOWN
Trial details
- NCT number
- NCT03887416
- Sponsor
- LM Diagnósticos S.L.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-12
- Primary completion
- 2020-02-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.